Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B
- PMID: 36198186
- DOI: 10.1056/NEJMc2210918
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B
Comment in
-
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. Reply.N Engl J Med. 2022 Oct 6;387(14):1336-1337. doi: 10.1056/NEJMc2210918. N Engl J Med. 2022. PMID: 36198187 No abstract available.
Comment on
-
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.N Engl J Med. 2022 Jul 21;387(3):237-247. doi: 10.1056/NEJMoa2119913. N Engl J Med. 2022. PMID: 35857660 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources